Gaithersburg, Maryland, May 14, 2025 – Navitas Life Sciences today announces it was named a Fierce CRO Award finalist by Fierce Biotech in the Client Service and Partnership category.

What Makes Navitas Life Sciences Unique

End-to-End Clinical Research Expertise

Spanning over 35 years, our experience across Clinical, Regulatory, Safety, and Data Management services empowers us to serve as a one-stop partner for pharmaceutical, biotech, and public sector organizations. We’re not bound by silos; we integrate disciplines, drive synergy, and deliver holistic value from study startup to submission.

A Deeply Client-Centric Culture

Our approach is rooted in understanding the unique goals of every client and co-creating tailored solutions that evolve with their needs. This strong focus on client success has led to a 90% re-engagement rate, reflecting the trust, transparency, and satisfaction we deliver consistently.

Proven Success in Long-Term Partnerships

We excel in building enduring relationships that deliver measurable impact. Whether it’s a 20+ year collaboration with the NIH’s NIAMS division or a 12-year strategic partnership with a Top 5 pharma company, our ability to scale, innovate, and consistently perform sets us apart as a CRO clients can rely on.

The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards honor CROs that have demonstrated outstanding performance, innovation, and leadership in delivering high-quality research and development services. By recognizing the excellence of CROs, the awards aim to highlight the critical role they play in advancing life sciences research and improving patient outcomes.

Marty Boom, Global Head of Regulatory and Safety, said, “We couldn't be prouder of this recognition. Being named a finalist for Excellence in Client Service and Partnership by Fierce is a powerful testament to the passion and commitment our team brings to every client relationship. This honor speaks volumes about the strength of our partnerships, the trust our clients place in us, and the collaborative spirit that drives everything that we do at Navitas Life Sciences. Thank you to Fierce for this incredible acknowledgement, and congratulations to the other outstanding finalists! Let's keep raising the bar together.”

Louise Jebson, Chief Growth Officer, said, “What an incredible honour to be named a finalist in the Excellence in Client Service and Partnership category at the 2025 Fierce CRO Awards! This recognition reflects the unwavering dedication, deep expertise, and true spirit of collaboration that define both our team and our approach. To our clients and partners, thank you for your continued trust. To the Navitas Life Sciences team, your commitment to delivering meaningful outcomes is what makes achievements like this possible. To Fierce, thank you for shining a light on the value of strong, strategic partnerships in our industry. Proud moment for all of us at Navitas. Congratulations to all the finalists!”

The Fierce CRO Awards finalists were judged on: Innovation and Impact, Measurable Outcomes, Sustainability and Scalability and Ethical and Regulatory Adherence.

Fierce CRO Awards winners will be announced on June 18.

About Navitas Life Sciences

Navitas Life Sciences is a knowledge-driven, CRO offering bespoke solutions for pharma, biotech, devices, Federal and non-profits. We leverage rich insights and cutting-edge technology to ensure compliance, efficiency and accelerate your products to market. At Navitas Life Sciences, we believe in shaping a healthier tomorrow by Powering Possibilities, enabling life-changing treatments to reach patients faster, safer, and more effectively.

About Fierce Biotech                                                                                                                   

Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here.